Evidence map›Paper›PMID 29736841›Full record

Trial reportClinical pharmacokinetics2019

Evaluation of the Interaction of Amino Acid Infusion on

Alicja Puszkiel, Mathilde Bauriaud-Mallet, Roxane Bourgeois, Lawrence Dierickx, Frédéric Courbon, Etienne Chatelut

Abstract readClinical Trial
PubMed Publisher
In one paragraph

Trial report in Clinical pharmacokinetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Influence of lanreotide on uptake ofEuropean journal of nuclear medicine and molecular imaging · 2019
    Trial
  2. Review
  3. Review
  4. The cycle effect quantified: reduced tumour uptake in subsequent cycles of [European journal of nuclear medicine and molecular imaging · 2024
    Article
  5. Predicting [EJNMMI physics · 2023
    Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alicja PuszkielInstitut Claudius-Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse, France.
Mathilde Bauriaud-MalletDepartment of Radiopharmacy, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
Roxane BourgeoisDepartment of Radiopharmacy, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
Lawrence DierickxDepartment of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
Frédéric CourbonDepartment of Medical Imaging, Institut Universitaire du Cancer Toulouse-Oncopole, Toulouse, France.
Etienne ChatelutInstitut Claudius-Regaud, Institut Universitaire du Cancer Toulouse-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse, France. chatelut.etienne@iuct-oncopole.fr.ORCID 0000-0002-7740-9096
Institut universitaire du cancer de Toulouse Oncopole · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objective

methods7.4 GBq of

results

conclusionsA substantial effect of AA co-infusion on

Indexed as

Models, BiologicalAdultAgedAged, 80 and overAmino AcidsAntineoplastic AgentsFemaleHumansInfusions, IntravenousIntestinal NeoplasmsKidneyLymphocyte CountMaleMiddle AgedNeuroendocrine TumorsOctreotideAmino AcidsAntineoplastic Agentslutetium Lu 177 dotatateOctreotideOrganometallic Compounds

Identifiers

PMID29736841
OpenAlexW2802020399

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.